Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Seminars in Radiation Oncology|March 12, 2010
Adaptive radiation therapy for prostate cancerMichel Ghilezan, Di Yan, Alvaro MartinezInternational Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation deliveryMichel Ghilezan, Di Yan, Jian Liang, et al.American Journal of Clinical Oncology|December 3, 2009
High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancerAlvaro A Martinez, Jeffrey Demanes, Carlos Vargas, et al.The Journal of Urology|August 12, 2005
A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapyCarlos Vargas, Michel Ghilezan, Mitchell Hollander, et al.International Journal of Radiation Oncology, Biology, Physics|June 30, 2010
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancerDaniel Krauss, Larry Kestin, Hong Ye, et al.International Journal of Radiation Oncology, Biology, Physics|February 12, 2011
High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancerD Jeffrey Demanes, Alvaro A Martinez, Michel Ghilezan, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 2007
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experienceK Kenneth Chao, Frank A Vicini, Michelle Wallace, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2020
Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancerJacob S Parzen, Hong Ye, Gary Gustafson, et al.Brachytherapy|October 24, 2009
PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivationSamuel D McGrath, J Vito Antonucci, Dwight L Fitch, et al.International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity dataMichel Ghilezan, Alvaro Martinez, Gary Gustason, et al.Pageof 1